Synzeal Research Profile
Key Indicators
- Authorised Capital ₹ 9.90 M
as on 03-07-2024
- Paid Up Capital ₹ 9.90 M
as on 03-07-2024
- Company Age 10 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 31.53 Cr
as on 03-07-2024
- Satisfied Charges ₹ 22.84 Cr
as on 03-07-2024
- Revenue 43.08%
(FY 2021)
- Profit 67.42%
(FY 2021)
- Ebitda 45.36%
(FY 2021)
- Net Worth 74.15%
(FY 2021)
- Total Assets 70.81%
(FY 2021)
About Synzeal Research
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 9.90 M and a paid-up capital of Rs 9.90 M.
The company currently has active open charges totaling ₹31.53 Cr. The company has closed loans amounting to ₹22.84 Cr, as per Ministry of Corporate Affairs (MCA) records.
Shailesh Patel, Jitendra Kaila, Rameshbhai Patel, and One other member serve as directors at the Company.
- CIN/LLPIN
U73200GJ2014PTC081295
- Company No.
081295
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Nov 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
- Apps
Who are the key members and board of directors at Synzeal Research?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jitendra Kaila  | Managing Director | 20-Nov-2014 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shailesh Patel | Director | 20-Nov-2014 | Current |
| Rameshbhai Patel | Director | 20-Nov-2014 | Current |
| Maghabhai Patel | Director | 01-May-2017 | Current |
Financial Performance of Synzeal Research.
Synzeal Research Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 43.08% increase. The company also saw a substantial improvement in profitability, with a 67.42% increase in profit. The company's net worth Soared by an impressive increase of 74.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Synzeal Research?
In 2021, Synzeal Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Synzeal Pharmachem Private LimitedActive 3 years 5 monthsShailesh Patel, Jitendra Kaila and 1 more are mutual person
Apisyn Healthcare Private LimitedActive 4 years 8 monthsShailesh Patel, Jitendra Kaila and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 05 Oct 2023 | ₹3.00 Cr | Open |
Others Creation Date: 30 May 2023 | ₹28.33 Cr | Open |
Others Creation Date: 20 Jun 2018 | ₹1.95 M | Open |
How Many Employees Work at Synzeal Research?
Synzeal Research has a workforce of 333 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Synzeal Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synzeal Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
